| Transurethral Resection Versus Transurethral Enucleation of the Prostate: Prospective Randomized Study (NCT05330156) | Assiut University | 2022-04-30 |
| Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH (NCT04987892) | NeoTract, Inc. | 2021-12-06 |
| Simulation-Based Enucleation Training: Initial Experience Using 3D-printed Organ Phantoms (NCT05628025) | Centre hospitalier de l'Université de Montréal (CHUM) | 2021-11-23 |
| SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia (NCT04826887) | University of Kansas Medical Center | 2021-04-14 |
| Long Term Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in Benign Prostatic Hyperplasia (BPH) Patients Who Completed 12 Months of Follow-Up Post Implantation (Continuation Study for Study BM-011-IL) (NCT05330520) | Butterfly Medical Ltd. | 2021-02-10 |
| Comparison Between Tamsulosin and Tadalafil in Management of Benign Prostatic Hyperplasia Long Term Study (NCT05818670) | Mansoura University | 2020-11-11 |
| Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia (NCT04398966) | University of North Carolina, Chapel Hill | 2020-09-23 |
| BE Technologies Mobile Uroflowmetry Validation Study (NCT04599283) | BE Technologies Inc | 2020-08-18 |
| Prospective Randomized Trial of Irritative Symptoms Severity Assessment After (HoLEP) Versus ThuFLEP (NCT04342533) | I.M. Sechenov First Moscow State Medical University | 2020-04-01 |
| Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy (NCT02961114) | Robert W. Alexander, MD, FICS | 2019-11-01 |
| Penthrox in Rezūm BPH (NCT04029012) | Dean Elterman | 2019-09-10 |
| An Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia (NCT05422677) | Hanmi Pharmaceutical Company Limited | 2019-07-15 |
| Effects of LycoComfort™ Supplementation on Symptoms Associated With Lower Urinary Tract Symptoms (LUTS) (NCT03772808) | LycoRed Ltd. | 2018-11-16 |
| Transperineal Laser Ablation for Percutaneous Treatment of Benign Prostatic Hyperplasia (NCT04198103) | University of Rome Tor Vergata | 2018-11-01 |
| Pilot Study to Assess the Safety and Efficacy of Butterfly Medical Prostatic Retraction Device in BPH Patients. (NCT03912558) | Butterfly Medical Ltd. | 2018-10-29 |
| Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study (NCT03600766) | Mansoura University | 2018-08-01 |
| LC Bead LUMI for Prostatic Artery Embolization (NCT03372096) | University of North Carolina, Chapel Hill | 2018-07-13 |
| Minimally Invasive Prostatic Vapor Ablation for the Treatment of BPH in Large Prostates (Rezūm XL) (NCT03605745) | Boston Scientific Corporation | 2018-06-19 |
| Virtual Visits at Brigham and Women's Hospital (NCT03592355) | Brigham and Women's Hospital | 2018-04-13 |
| Study to Assess the Efficacy, Safety and Tolerability of (iTind) (NCT03239951) | Medi-Tate Ltd. | 2018-02-27 |
| Study to Assess the Efficacy of the iTind in Subjects With Symptomatic BPH (NCT03395522) | Medi-Tate Ltd. | 2018-02-18 |
| Global Post-Market Registry Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (NCT02974751) | PROCEPT BioRobotics | 2017-09-05 |
| MRI Guided Transrectal Prostate Laser Ablation for Benign Prostatic Hypertrophy (BPH) (NCT03131544) | Prostate Laser Center, PLLC | 2017-04-17 |
| Transthoracic Echocardiographic Evaluation of the Cardiac Function During Transurethral Resection of Prostate in Elderly Patients (NCT02288780) | Yonsei University | 2014-12-01 |
| Efficacy of Prunus Domestica Extract in BPH (NCT02702947) | Chemical Resources | 2014-03-01 |
| Moxibustion as an Adjuvant for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: a Pilot Study (NCT02051036) | JUNGNAM KWON | 2014-02-01 |
| Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)(NX02-0022) (NCT01846793) | Nymox Corporation | 2013-04-01 |
| Explorative Study of Degarelix for Treatment of Benign Prostatic Hyperplasia. (NCT00527488) | Ferring Pharmaceuticals | 2007-10-01 |
| Urokinase Plasminogen Activator System in Benign Prostatic Hyperplasia (NCT00407329) | Queen's University | 2006-11-01 |
| The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH Patients (NCT00696761) | Asan Medical Center | 2006-05-01 |
| Uroxatral in Men With Benign Prostate Hypertrophy (BPH) and Erectile Dysfunction (ED) (NCT00256399) | University Hospitals Cleveland Medical Center | 2005-11-01 |
| Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP) (NCT00199550) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2004-05-01 |
| A Clinical Study to Determine Factors Affecting Absorption and Serum Levels of Lycopene After Supplementation (NCT00154843) | National Taiwan University Hospital | 2004-03-01 |
| 5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression (NCT02876757) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2003-01-01 |
| Safety/Tolerability Study of Alcohol Injection for Treatment of BPH (Enlarged Prostate) (NCT00037141) | American Medical Systems | 2002-03-01 |